このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
McKesson 過去の業績
過去 基準チェック /26
McKessonは38.5%の年平均成長率で業績を伸ばしているが、Healthcare業界はgrowingで5.6%毎年増加している。売上は成長しており、年平均7.1%の割合である。
主要情報
38.5%
収益成長率
41.8%
EPS成長率
Healthcare 業界の成長 | 8.5% |
収益成長率 | 7.1% |
株主資本利益率 | n/a |
ネット・マージン | 1.0% |
前回の決算情報 | 31 Mar 2024 |
最近の業績更新
Recent updates
With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For
May 09Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?
Mar 14McKesson: GLP-1 Contributed More Than 1/3 Of Growth
Feb 19McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues
Feb 16Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking
Jan 29McKesson: Why The Company Is Too Richly Valued
Jan 19If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity
Nov 20McKesson: GLP-1 Medications Tailwinds And Massive Share Repurchase
Nov 08Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?
Oct 30McKesson: Still Trading For A Huge Discount
Sep 06Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors
Aug 21Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?
Jul 27McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation
Jun 28Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors
May 23Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?
Apr 17Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?
Feb 22McKesson Corporation: Looking Forward To Long-Term Low-Teens EPS Growth
Feb 08McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M
Feb 01McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price
Jan 125 Reasons Why I Am Considering Adding McKesson To My Portfolio
Dec 27McKesson Corporation: Still Trading Below Intrinsic Value
Dec 13Duration: The Time Bomb In Your Portfolio - McKesson And PayPal In Focus
Oct 08McKesson extends distribution partnership with CVS Health
Sep 29An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% Undervalued
Sep 19McKesson to acquire Rx Savings Solutions in $875M deal
Sep 19Cardinal Health, McKesson hit 52-week highs; up 35% and 50% YTD
Aug 15McKesson raises fiscal 2023 adjusted diluted EPS following strong quarterly results
Aug 03McKesson raises dividend by 15% to $0.54/share
Jul 25McKesson Is Still An Attractive Dividend Growth Stock
Jul 10McKesson: Best Of Breed In Drug Distributor Oligopoly
Jun 20収支内訳
収支内訳
McKesson の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
31 Mar 24 | 308,951 | 3,002 | 8,010 | 0 |
31 Dec 23 | 301,506 | 2,998 | 7,785 | 0 |
30 Sep 23 | 291,098 | 3,487 | 7,838 | 0 |
30 Jun 23 | 284,040 | 3,755 | 7,881 | 0 |
31 Mar 23 | 276,711 | 3,563 | 7,980 | 0 |
31 Dec 22 | 273,903 | 3,146 | 8,258 | 0 |
30 Sep 22 | 272,027 | 2,061 | 8,438 | 0 |
30 Jun 22 | 268,446 | 1,396 | 8,702 | 0 |
31 Mar 22 | 263,966 | 1,119 | 8,937 | 0 |
31 Dec 21 | 257,006 | 1,415 | 8,918 | 0 |
30 Sep 21 | 250,991 | -4,804 | 8,926 | 0 |
30 Jun 21 | 245,223 | -4,494 | 8,919 | 0 |
31 Mar 21 | 238,228 | -4,538 | 8,791 | 0 |
31 Dec 20 | 237,621 | -4,189 | 8,696 | 0 |
30 Sep 20 | 234,194 | 2,228 | 8,875 | 0 |
30 Jun 20 | 231,002 | 922 | 8,864 | 0 |
31 Mar 20 | 231,051 | 906 | 8,907 | 0 |
31 Dec 19 | 224,945 | -905 | 9,641 | 71 |
30 Sep 19 | 221,981 | -626 | 9,160 | 71 |
30 Jun 19 | 217,440 | 601 | 8,642 | 71 |
31 Mar 19 | 214,319 | 33 | 8,437 | 0 |
31 Dec 18 | 213,518 | -319 | 8,362 | 125 |
30 Sep 18 | 210,927 | 113 | 8,197 | 125 |
30 Jun 18 | 209,913 | -384 | 8,300 | 125 |
31 Mar 18 | 208,357 | 62 | 8,138 | 125 |
31 Dec 17 | 205,442 | 4,805 | 7,464 | 341 |
30 Sep 17 | 201,955 | 4,539 | 7,503 | 341 |
30 Jun 17 | 199,851 | 4,846 | 7,317 | 341 |
31 Mar 17 | 198,533 | 5,194 | 7,447 | 341 |
31 Dec 16 | 196,498 | 2,051 | 7,149 | 392 |
30 Sep 16 | 194,267 | 2,044 | 7,264 | 392 |
30 Jun 16 | 193,071 | 2,359 | 7,283 | 392 |
31 Mar 16 | 190,884 | 2,290 | 7,379 | 392 |
31 Dec 15 | 189,131 | 2,237 | 7,573 | 392 |
30 Sep 15 | 187,716 | 2,090 | 7,342 | 392 |
30 Jun 15 | 183,115 | 1,950 | 7,781 | 392 |
31 Mar 15 | 179,045 | 1,775 | 7,901 | 392 |
31 Dec 14 | 171,952 | 1,780 | 7,323 | 457 |
30 Sep 14 | 159,804 | 1,462 | 6,932 | 457 |
30 Jun 14 | 148,629 | 1,402 | 6,143 | 457 |
31 Mar 14 | 137,392 | 1,419 | 5,388 | 457 |
31 Dec 13 | 130,076 | 1,278 | 4,675 | 433 |
30 Sep 13 | 126,839 | 1,420 | 4,554 | 433 |
30 Jun 13 | 123,609 | 1,396 | 4,298 | 433 |
質の高い収益: MCKは 高品質の収益 を持っています。
利益率の向上: MCKの現在の純利益率 (1%)は、昨年(1.3%)よりも低くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: MCKの収益は過去 5 年間で年間38.5%増加しました。
成長の加速: MCKは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。
収益対業界: MCKは過去 1 年間で収益成長率がマイナス ( -15.7% ) となったため、 Healthcare業界平均 ( 15.1% ) と比較することが困難です。
株主資本利益率
高いROE: MCKの負債は資産を上回っているため、自己資本利益率を計算することは困難です。